Celldex Therapeutics, Inc. Stock London S.E.
Stocks
0HUU
US15117B2025
Biotechnology & Medical Research
|
Delayed
London S.E.
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 09-22 | Top Midday Decliners | MT |
| 09-22 | Celldex Therapeutics, Inc. - Special Call |
| Market Cap | 2.44B 2.14B 2.02B 1.84B 3.44B 234B 3.47B 24.22B 9.39B 119B 9.18B 8.98B 387B | P/E 2026 * |
-7.42x | P/E 2027 * | -7.29x |
|---|---|---|---|---|---|
| Enterprise Value | 1.78B 1.56B 1.47B 1.34B 2.51B 171B 2.53B 17.65B 6.84B 87.01B 6.69B 6.54B 282B | EV / Sales 2026 * |
963x | EV / Sales 2027 * | 182x |
| Free-Float |
99.73% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Celldex Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Tibor Keler
CTO | Chief Tech/Sci/R&D Officer | 67 | 30/07/2014 |
Anthony Marucci
CEO | Chief Executive Officer | 64 | 01/09/2008 |
Sam Martin
DFI | Director of Finance/CFO | 55 | 01/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Marucci
BRD | Director/Board Member | 64 | 01/12/2008 |
Harry Penner
CHM | Chairman | 80 | 05/06/2025 |
Herbert Conrad
BRD | Director/Board Member | 93 | 01/03/2008 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 2.44B | |
| +0.53% | +3.74% | +7.78% | +30.85% | 47.56B | |
| -0.83% | -0.36% | +43.66% | +34.77% | 44.09B | |
| -0.84% | +4.86% | +10.92% | +91.52% | 41.5B | |
| -1.10% | -2.64% | +331.49% | +535.80% | 40.88B | |
| -0.62% | +0.11% | +1.12% | +46.02% | 29.67B | |
| -2.07% | +0.12% | +24.39% | +154.30% | 17.23B | |
| +1.29% | +0.34% | +24.62% | +40.92% | 15.06B | |
| -6.08% | -9.92% | - | - | 14.65B | |
| -0.78% | +9.46% | -8.96% | - | 13.82B | |
| Average | -1.32% | +0.69% | +54.38% | +133.45% | 29.39B | |
| Weighted average by Cap. | -0.92% | +0.96% | +68.05% | +141.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.85M 1.62M 1.53M 1.4M 2.61M 177M 2.63M 18.33M 7.11M 90.35M 6.95M 6.79M 293M | 9.95M 8.74M 8.21M 7.51M 14.03M 954M 14.14M 98.65M 38.24M 486M 37.38M 36.56M 1.58B |
| Net income | -319M -280M -263M -241M -450M -30.57B -453M -3.16B -1.23B -15.59B -1.2B -1.17B -50.54B | -361M -317M -298M -272M -509M -34.58B -513M -3.58B -1.39B -17.63B -1.36B -1.33B -57.15B |
| Net Debt | -662M -581M -546M -500M -934M -63.44B -940M -6.56B -2.54B -32.35B -2.49B -2.43B -105B | -633M -556M -523M -478M -893M -60.68B -900M -6.28B -2.43B -30.94B -2.38B -2.33B -100B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CLDX Stock
- 0HUU Stock
Select your edition
All financial news and data tailored to specific country editions
